Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Brufman

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Anticancer Research|July 1, 1993
Prognostic factors affecting response to aminoglutethimide in advanced breast cancerG Brufman
Harefuah|December 16, 1984
[Treatment of metastatic breast cancer with aminoglutethimide after failure of tamoxifen]G Brufman, S Biran
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 1, 1985
Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifenG Brufman, S Biran
Anticancer Research|September 1, 1986
Aminoglutethimide as second line endocrine therapy in advanced breast cancerG Brufman, S Biran
Anticancer Research|July 1, 1986
Prognostic factors affecting treatment results with combination chemotherapy in metastatic breast cancerG Brufman, S Biran
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Second line hormonal therapy with aminoglutethimide in metastatic breast cancerG Brufman, S Biran
Harefuah|November 1, 1976
[Spontaneous pneumothorax complicating neoplastic diseases]G Brufman, S Biran
Oncology|January 1, 1981
Cyclic combination chemotherapy for metastatic breast cancer: comparison of two CMF schedulesS Biran, G Brufman
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1988
Adjuvant chemotherapy with and without radiotherapy in stage II breast cancerG Brufman, A Sulkes, S Biran
Harefuah|August 1, 1977
[Life-threatening gastrointestinal toxicity during 5-fluorouracil therapy]S Biran, D krasnokuki, G Brufman
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Anticancer Research|July 1, 1993
Prognostic factors affecting response to aminoglutethimide in advanced breast cancerG Brufman
Harefuah|December 16, 1984
[Treatment of metastatic breast cancer with aminoglutethimide after failure of tamoxifen]G Brufman, S Biran
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 1, 1985
Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifenG Brufman, S Biran
Anticancer Research|September 1, 1986
Aminoglutethimide as second line endocrine therapy in advanced breast cancerG Brufman, S Biran
Anticancer Research|July 1, 1986
Prognostic factors affecting treatment results with combination chemotherapy in metastatic breast cancerG Brufman, S Biran
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Second line hormonal therapy with aminoglutethimide in metastatic breast cancerG Brufman, S Biran
Harefuah|November 1, 1976
[Spontaneous pneumothorax complicating neoplastic diseases]G Brufman, S Biran
Oncology|January 1, 1981
Cyclic combination chemotherapy for metastatic breast cancer: comparison of two CMF schedulesS Biran, G Brufman
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1988
Adjuvant chemotherapy with and without radiotherapy in stage II breast cancerG Brufman, A Sulkes, S Biran
Harefuah|August 1, 1977
[Life-threatening gastrointestinal toxicity during 5-fluorouracil therapy]S Biran, D krasnokuki, G Brufman
Pageof 5